Mercia Technologies has invested £2 million into Medherant, a company developing transdermal delivery products for pain and CNS diseases. The additional funding is part of a nearly £2.4 million syndicated investment round. Medherant is a spin out of the University of Warwick and received its first investment from Mercia in 2015. Since the initial funding, […]
